Progress in Medical Physics (한국의학물리학회지:의학물리)

Korean Society of Medical Physics (한국의학물리학회)
권호 표지
DOI QR코드

DOI QR Code

Proton Therapy Review: Proton Therapy from a Medical

  • Lee, Se Byeong (Department of Radiation Oncology & Proton Therapy Center, National Cancer Center)
  • Received : 2020.07.27
  • Accepted : 2020.09.09
  • Published : 2020.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

With hope and concern, the first Korean proton therapy facility was introduced to the National Cancer Center (NCC) in 2007. It added a new chapter to the history of Korean radiation therapy. There have been challenging clinical trials using proton beam therapy, which has seen many impressive results in cancer treatment. Compared to the rapidly increasing number of proton therapy facilities in the world, only one more proton therapy center has been added since 2007 in Korea. The Samsung Medical Center installed a proton therapy facility in 2015. Most radiation oncology practitioners would agree that the physical properties of the proton beam provide a clear advantage in radiation treatment. But the expensive cost of proton therapy facilities is still one of the main reasons that hospitals are reluctant to introduce them in Korea. I herein introduce the history of proton therapy and the cutting edge technology used in proton therapy. In addition, I will cover the role of a medical physicist in proton therapy and the future prospects of proton therapy, based on personal experience in participating in proton therapy programs from the beginning at the NCC.

Keywords

Acknowledgement

I would like to appreciate IBA and Mevion that they provided their picture and technical information of their proton therapy solution. I also would like to thank people in proton therapy center, NCC for their valuable discussion for proton therapy system.

References

  1. Leo WR: The bethe-bloch formula. Techniques for nuclear and particle physics experiments. 2nd ed. Berlin, Heidelberg: Spriger-Verlag; 1994.
  2. Shin J, Park S, Kim H, Kim M, Jeong C, Cho S, et al. Proton linear energy transfer measurement using emulsion cloud chamber. Nucl Instrum Methods Phys Res B. 2015;349:201-208. https://doi.org/10.1016/j.nimb.2014.12.083
  3. International Commission on Radiation Units & Measurements. Report 78: prescribing, recording, and reporting proton-beam therapy. Bethesda: International Commission on Radiation Units & Measurements; 2007.
  4. Baek HJ, Kim TH, Shin D, Kwak JW, Choo DW, Lee SB, et al. Radiobiological characterization of proton beam at the National Cancer Center in Korea. J Radiat Res. 2008;49:509-515. https://doi.org/10.1269/jrr.08017
  5. Lawrence E, Livingston M. The production of high speed protons without the use of high voltages. Phys Rev. 1931;38:834. https://doi.org/10.1103/PhysRev.38.834
  6. Giap H, Giap B. Historical perspective and evolution of charged particle beam therapy. Transl Cancer Res. 2012;1:127-136.
  7. Particle Therapy Co-Operative Group. Facilties in operation. Taipei: Particle Therapy Co-Operative Group, 2020 [cited 2020 May 13]. Available from: https://www.ptcog.ch.
  8. Kim JY. Korea's first proton therapy center. Ilsan: Proton Therapy Today, 2012 [cited 2020 May 14]. Available from: http://www.proton-therapy-today.com/koreas-first-proton-therapy-center/.
  9. Shin D, Yoon M, Kwak J, Shin J, Lee SB, Park SY, et al. Secondary neutron doses for several beam configurations for proton therapy. Int J Radiat Oncol Biol Phys. 2009;74:260-265. https://doi.org/10.1016/j.ijrobp.2008.10.090
  10. Jeong H, Rah JE, Hwang UJ, Yoo SH, Min BJ, Lee SY, et al. Estimation of the secondary cancer risk induced by diagnostic imaging radiation during proton therapy. J Radiol Prot. 2011;31:477-487. https://doi.org/10.1088/0952-4746/31/4/007
  11. Li X, Liu G, Janssens G, De Wilde O, Bossier V, Lerot X, et al. The first prototype of spot-scanning proton arc treatment delivery. Radiother Oncol. 2019;137:130-136. https://doi.org/10.1016/j.radonc.2019.04.032
  12. Ding X, Li X, Zhang JM, Kabolizadeh P, Stevens C, Yan D. Spot-Scanning Proton Arc (SPArc) therapy: the first robust and delivery-efficient spot-scanning proton arc therapy. Int J Radiat Oncol Biol Phys. 2016;96:1107-1116. https://doi.org/10.1016/j.ijrobp.2016.08.049
  13. Wilson JD, Hammond EM, Higgins GS, Petersson K. Ultrahigh dose rate (FLASH) radiotherapy: silver bullet or fool's gold? Front Oncol. 2020;9:1563. https://doi.org/10.3389/fonc.2019.01563
  14. Patriarca A, Fouillade C, Auger M, Martin F, Pouzoulet F, Nauraye C, et al. Experimental set-up for FLASH proton irradiation of small animals using a clinical system. Int J Radiat Oncol Biol Phys. 2018;102:619-626. https://doi.org/10.1016/j.ijrobp.2018.06.403
  15. Beyreuther E, Brand M, Hans S, Hideghety K, Karsch L, Lessmann E, et al. Feasibility of proton FLASH effect tested by zebrafish embryo irradiation. Radiother Oncol. 2019; 139:46-50. https://doi.org/10.1016/j.radonc.2019.06.024
  16. Diffenderfer ES, Verginadis II, Kim MM, Shoniyozov K, Velalopoulou A, Goia D, et al. Design, implementation, and in vivo validation of a novel proton FLASH radiation therapy system. Int J Radiat Oncol Biol Phys. 2020;106:440-448. https://doi.org/10.1016/j.ijrobp.2019.10.049
  17. Paganetti H. Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys Med Biol. 2012; 57:R99-R117. https://doi.org/10.1088/0031-9155/57/11/R99
  18. Handrack J, Tessonnier T, Chen W, Liebl J, Debus J, Bauer J, et al. Sensitivity of post treatment positron emission tomography/computed tomography to detect inter-fractional range variations in scanned ion beam therapy. Acta Oncol. 2017;56:1451-1458. https://doi.org/10.1080/0284186X.2017.1348628
  19. Kurz C, Bauer J, Unholtz D, Richter D, Herfarth K, Debus J, et al. Initial clinical evaluation of PET-based ion beam therapy monitoring under consideration of organ motion. Med Phys. 2016;43:975-982. https://doi.org/10.1118/1.4940356
  20. Min CH, Kim CH, Youn MY, Kim JW. Prompt gamma measurements for locating the dose falloff region in the proton therapy. Appl Phys Lett. 2006;89:183517. https://doi.org/10.1063/1.2378561
  21. Gensheimer MF, Yock TI, Liebsch NJ, Sharp GC, Paganetti H, Madan N, et al. In vivo proton beam range verification using spine MRI changes. Int J Radiat Oncol Biol Phys. 2010;78:268-275. https://doi.org/10.1016/j.ijrobp.2009.11.060
  22. Arjomandy B, Taylor P, Ainsley C, Safai S, Sahoo N, Pankuch M, et al. AAPM task group 224: comprehensive proton therapy machine quality assurance. Med Phys. 2019;46: e678-e705.
  23. Schneider U, Pemler P, Besserer J, Pedroni E, Lomax A, Kaser-Hotz B. Patient specific optimization of the relation between CT-hounsfield units and proton stopping power with proton radiography. Med Phys. 2005;32:195-199.
  24. Jo K, Kim MY, Jeong JH, Jeang EH, Kim H, Park S, et al. A practical experience of dose modeling for proton pencil beam scanning in KNCC. J Korean Phys Soc. 2015;67:108-115. https://doi.org/10.3938/jkps.67.108
  25. Kim DW, Lim YK, Shin J, Ahn S, Shin MY, Lee SB, et al. A dose verification method for proton therapy by using a plastic scintillation plate. J Korean Phys Soc. 2009;55:702-708. https://doi.org/10.3938/jkps.55.702
  26. Cho S, Lee N, Song S, Son J, Kim H, Jeong JH, et al. Toward a novel dosimetry system using acrylic disk radiation sensor for proton pencil beam scanning. Med Phys. 2018;45:5277-5282. https://doi.org/10.1002/mp.13149
  27. Shin J, Kim D, Lim YK, Ahn S, Shin D, Yoon MG, et al. Monte Carlo modeling and simulation of a passive treatment proton beam delivery system using a modulation wheel. J Korean Phys Soc. 2010;56:153-163. https://doi.org/10.3938/jkps.56.153
  28. Kim DH, Kang YN, Suh TS, Shin J, Kim JW, Yoo SH, et al. Monte Carlo modeling and validation of a proton treatment nozzle by using the Geant4 toolkit. J Korean Phys Soc. 2012; 61:1125-1130. https://doi.org/10.3938/jkps.61.1125
  29. Shin WG, Testa M, Kim HS, Jeong JH, Lee SB, Kim YJ, et al. Independent dose verification system with Monte Carlo simulations using TOPAS for passive scattering proton therapy at the National Cancer Center in Korea. Phys Med Biol. 2017;62:7598-7616. https://doi.org/10.1088/1361-6560/aa8663
  30. Lee SH, Cho S, You SH, Shin D, Park SY, Lee SB, et al. Evaluation of radioactivity induced by patient-specific devices in proton therapy. J Korean Phys Soc. 2012;60:125-128. https://doi.org/10.3938/jkps.60.125
  31. Lim YK, Kwak J, Kim DW, Shin D, Yoon M, Park S, et al. Microscopic gold particle-based fiducial markers for proton therapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2009;74:1609-1616. https://doi.org/10.1016/j.ijrobp.2009.02.076
  32. Kwak J, Shin J, Kim JS, Park SY, Shin D, Yoon M, et al. Dosimetric influence of implanted gold markers in proton therapy for prostate cancer. Korean J Med Phys. 2010;21:291-297.
  33. Sanchez-Parcerisa D, Lopez-Aguirre M, Dolcet Llerena A, Udias JM. MultiRBE: Treatment planning for protons with selective radiobiological effectiveness. Med Phys. 2019;46: 4276-4284. https://doi.org/10.1002/mp.13718
  34. Park S, Jeong C, Kang DY, Shin JI, Cho S, Park JH, et al. Proton-radiography-based quality assurance of proton range compensator. Phys Med Biol. 2013;58:6511-6523. https://doi.org/10.1088/0031-9155/58/18/6511
  35. Kim DW, Lim YK, Ahn SH, Shin J, Shin D, Yoon M, et al. Prediction of output factor, range, and spread-out Bragg peak for proton therapy. Med Dosim. 2011;36:145-152. https://doi.org/10.1016/j.meddos.2010.02.006